Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-064102

Chief Scientific Officer acquired 20,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2018-12-21 Option exercise +20,500 $2.34 $47,919 24,637 D
Derivatives
Biller Scott Chief Scientific Officer 2018-12-21 Option exercise · Stock option (right to buy) −20,500 7,218 D
Loading xslF345X03/doc4.xml…